BioNTech SE is currently sponsoring a Phase II clinical study titled A Phase II, Multisite, Open-label, Single Arm Trial of BNT327 in Combination With Docetaxel in Second-line Stage IV Non-small Cell ...

Earlier this week, I posted a question on social media. It went something like this, “Without sarcasm, political insults or ...

TORONTO, Aug. 22, 2025 /CNW/ - With thousands of press releases published each week, it can be difficult to keep up with ...

The payoff in lives and hospital time saved runs at about 100 to 1 per dollar invested, which is a great deal by any standard ...

New data from the Kentucky Cabinet for Health and Family Services shows cases of the virus have jumped significantly in the ...

Since COVID, there've been growing initiatives in Africa to start producing vaccines and medicines locally, thus gaining greater independence from global supply chains. But are these schemes ...

The Emeryville, California-based biotech has just released topline results from a phase 1/2 head-to-head study comparing its ...

The immune system’s role is usually seen as wiping out invading pathogens like bacteria and viruses, but several types of ...

Dr. James Hildreth, president and CEO of Meharry Medical College and a veteran epidemiologist, said he was "baffled" by the unprecedented move. He and others thought of it as a foreshadowing that ...

“This usual chain of decisions … has been disrupted. And without clarity and coordination, millions may not be able to have ...

As a summer COVID-19 surge hits Michigan, unanswered questions abound about eligibility, insurance coverage and when new ...